Navigation Links
European Hearing Aids and Audiology Devices Market
Date:3/7/2013

ands by Leading Competitors 270

DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET 271

13.1 INTRODUCTION 27113.2MARKET OVERVIEW 27213.3MARKET ANALYSIS AND FORECAST 27813.3.1 Total Diagnostic Coronary Catheter and Guidewire Market 27813.4 DIAGNOSTIC CATHETER MARKET 28613.5 DIAGNOSTIC GUIDEWIRE MARKET 29413.6MARKET DRIVERS AND LIMITERS 30213.6.1 Market Drivers 30213.6.2 Market Limiters 30213.7 COMPETITIVE ANALYSIS 30413.7.1 Brands by Leading Competitors 309

FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET 310

14.1 INTRODUCTION 31014.2MARKET ANALYSIS AND FORECAST 31114.3MARKET DRIVERS AND LIMITERS 31914.3.1 Market Drivers 31914.3.2 Market Limiters 31914.4 COMPETITIVE ANALYSIS 32014.4.1 Brands by Leading Competitors 322

CORONARY VASCULAR CLOSURE DEVICE MARKET 323

15.1 INTRODUCTION 32315.1.1 Invasive and Non-Invasive Devices 32315.2MARKET OVERVIEW 32415.3MARKET ANALYSIS AND FORECAST 33015.3.1 Total Coronary VCD Market 33015.3.2 Total Coronary VCD Market by Access Site 33815.3.3 Invasive Coronary VCD Market 34015.3.4 Non-Invasive Coronary VCD Market 34815.4MARKET DRIVERS AND LIMITERS 35615.4.1 Market Drivers 35615.4.2 Market Limiters 35615.5 COMPETITIVE ANALYSIS 35815.5.1 Brands by Leading Competitors 361

INTRAVASCULAR ULTRASOUND CATHETER MARKET 362

16.1 INTRODUCTION 36216.1.1 Pre-Stenting Applications 36216.1.2 Post-Stenting Applications 36316.1.3 IVUS Console Penetration 36316.2MARKET ANALYSIS AND FORECAST 36416.3 PENETRATION RATE 37216.4MARKET DRIVERS AND LIMITERS 37316.4.1 Market Drivers 37316.4.2 Market Limiters 37416.5 COMPETITIVE ANALYSIS 37516.5.1 Brands by Leading Competitors 378

OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET 379

17.1 INTRODUCTION 37917.1.1 OCT Applications 38017.2MARKET ANALYSIS AND FORECAST 38117.3 PENETRATION RATE 38917.4MARKET DRIVERS AND LIMITERS 39017.4.1 Market Drivers 39017.4.2 Market Limiters 39117.5 COMPETITIVE ANALYSIS 39217.5.1 Bramds by Leading Competitors 393

VU
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
2. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
3. BioElectronics Expands European Distribution to Malta
4. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
5. Cardica Updates Enrollment Progress In European Clinical Trial
6. Hologic to Showcase Game-Changing Breast Tomosynthesis Technology and Other Product Innovations at the European Congress of Radiology in Vienna
7. Gro-International to Develop BioElectronics OTC Brands in European and African Markets
8. European Diagnostic Imaging System Market Will Grow Modestly To Almost $2.2 Billion In 2017
9. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
10. Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Companys Patented "IPF" HIV-AIDS Medicines
11. OrbusNeich Announces Favorable Ruling From the European Patent Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
(Date:7/2/2015)... 2, 2015 The report "Silage ... Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), ... 2020", Silage Inoculants & Enzymes Market is expected to ... 4.0% from 2015 to 2020. Browse ... through 194 P ages and an ...
(Date:7/2/2015)... 2 de julio de 2015 BGI anunció ... de alto rendimiento en Hong Kong ... of Pathologists (CAP). La instalación de BGI en ... secuenciación de próxima generación que recibe la certificación CAP ... alto estándar en prácticas de laboratorio clínico. Junto con ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI recibe la acreditación del College of American Pathologists (CAP) 2
... connectivity enabled by Unlimited Systems Interlink integration platform, Navigating ... cancer clinics easily meet many of the HITECH Act ... and money by reducing duplicate data entry, streamlining patient ... and reduced denials. Clinics can provide patients ...
... N.J., Oct. 18, 2011 Johnson & Johnson (NYSE: ... the third quarter of 2011, an increase of 6.8% as ... 2.6% and the positive impact of currency was 4.2%.  Domestic ... of 8.3% and a positive currency impact of 8.1%. ...
Cached Medicine Technology:Navigating Cancer and Unlimited Systems Partner to Provide Cancer Clinics With IT Interoperability to Attain HITECH Act Incentives 2Johnson & Johnson Reports 2011 Third-Quarter Results 2Johnson & Johnson Reports 2011 Third-Quarter Results 3Johnson & Johnson Reports 2011 Third-Quarter Results 4Johnson & Johnson Reports 2011 Third-Quarter Results 5Johnson & Johnson Reports 2011 Third-Quarter Results 6Johnson & Johnson Reports 2011 Third-Quarter Results 7Johnson & Johnson Reports 2011 Third-Quarter Results 8Johnson & Johnson Reports 2011 Third-Quarter Results 9Johnson & Johnson Reports 2011 Third-Quarter Results 10Johnson & Johnson Reports 2011 Third-Quarter Results 11Johnson & Johnson Reports 2011 Third-Quarter Results 12Johnson & Johnson Reports 2011 Third-Quarter Results 13Johnson & Johnson Reports 2011 Third-Quarter Results 14
(Date:7/3/2015)... ... July 03, 2015 , ... The ... June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. ... bicyclists and practical points of investigating these types of cases. , Each year, ...
(Date:7/3/2015)... ... 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director of ... of independent freestanding emergency rooms in the United States. , “We are excited to ... said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
(Date:7/3/2015)... Abilene, Texas (PRWEB) , ... July 03, 2015 , ... ... published a new article this week that he says will reveal biblical truth and ... article titled “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
(Date:7/2/2015)... ... 2015 , ... Following the recent report by JAMA Internal Medicine ... overweight Americans, Samir Becic emphatically declared a war on obesity in the United States. ... said. "We must understand the magnitude of this discovery. For that reason, I am ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... 3 (HealthDay News) -- People with mental illness are ... serious cardiac event, a new study finds. One ... mental illness are 14 percent less likely to receive ... Those treatments included coronary artery bypass graft (bypass surgery) ...
... , THURSDAY, June 2 (HealthDay News) -- A class ... doesn,t boost the risk of cancer, as a recent ... drugs are known as angiotensin-receptor blockers (ARBs) and include ... and candesartan (Atacand). The determination comes from ...
... -- Poor sleep may be a factor in aggressive behavior ... who bully other kids are more likely to be sleepy ... the University of Michigan Medical School found that children with ... have sleep-disordered breathing problems or daytime sleepiness as other children ...
... investigates the challenges that pen and paper workarounds ... of electronic health records. Understanding these challenges may ... health IT. Focusing on referrals by primary ... specialists back to the referring physician, "Paper Persistence, ...
... American Society of Clinical Oncology (ASCO) Annual Meeting, cancer ... treating recurrent gliobastoma (GBM) has a favorable safety profile ... than the current median survival rate. Patients in ... University of California, San Francisco and Columbia University, were ...
... When earthquake, tsunami, tornado or flood strike, among the ... International Journal of Emergency Management , researchers in ... into account the age-related needs of adults with regards ... Robyn Tuohy and Christine Stephens of Massey University ...
Cached Medicine News:Health News:Mental Illness Linked to Greater Risk of Death After Heart Attack 2Health News:Popular Blood Pressure Meds Not Linked to Cancer, FDA Says 2Health News:Kids Who Bully Often Get Poor Sleep 2Health News:Paper and computer workarounds challenge but may improve health IT 2Health News:Paper and computer workarounds challenge but may improve health IT 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 4Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 5Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 6Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 7Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 8Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 9Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 10Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 11Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 12Health News:Helping the aged during natural disasters 2
Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... for the semi-quantitative determination of specific ... serum. The results of the anti-GBM.assay ... in the diagnosis of diseases associated ... including Goodpastures Syndrome. Levels of these ...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of LH in human serum or plasma. LH in the sample is bound by 2 monoclonal anti-LH antibodies directed at different epito...
Medicine Products: